ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, ...

Bioxyne's (ASX:BXN) latest $3 million capital raise has gained piqued interest from new and existing institutional investors ...

Bioxyne has received firm commitments to raise $3 million in a placement to support expansion into European markets along ...

Penington Institute has written to several Australian premiers and chief ministers, urging them to fix road laws for medical ...

There are new calls to overhaul a driving law in one state, with claims Aussies shouldn’t be forced to choose between their ...

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of ...

In 2023, global cannabis sales were estimated at $32 billion, with North America dominating over 75% of total revenue due to widespread legalization in the U.S. and Canada. However, international ...

“Medical cannabis patients should not be forced to ... Tasmania is the only Australian state where driving with medicinal cannabis in one’s system is legal. However, Victoria leaves it to ...

Tilray, Gibraltar Industries, Innovative Industrial Properties, Turning Point Brands, Indivior, Canopy Growth, and AFC Gamma are the seven Cannabis stocks to watch today, according to MarketBeat’s ...

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we’ll ...